Effects of Estrogen Metabolite 2-Methoxyestradiol on Tumor Suppressor Protein p53 and Proliferation of Breast Cancer Cells

Systems Biology in Reproductive Medicine

Volumn 57, Issue 6, 2011, Pages 279-287

  Siebert, Amy E ^a   Sanchez, Amelita L ^a   Dinda, Sumi ^a   Moudgil, Virinder K ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

2 Methoxyestradiol; Breast cancer; Estrogen; P53; Tumor suppressor protein

Indexed keywords

2 METHOXYESTRADIOL; ESTRADIOL; PACLITAXEL; PROTEIN P53;

BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONFLUENT AND RETICULATED PAPILLOMATOSIS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTRADIOL; HUMANS; MICROSCOPY, CONFOCAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 81755171160     PISSN: 19396368     EISSN: 19396368     Source Type: Journal    
DOI: 10.3109/19396368.2011.633152     Document Type: Conference Paper

References (65)

1. Agrawal, S.S. and Alvin Jose, M. (2010) Roxatidine, an H(2) receptor blocker, is an estrogenic compound-experimental evidence. Syst Biol Reprod Med 56:286-291.
2. Attalla, H., Makela, T.P., Adlercreutz, H. and Andersson, L.C. (1996) 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Commun 228:467-473. (Pubitemid 26396096)
3. Azab, S.S., Salama, S.A., Abdel-Naim, A.B., Khalifa, A.E., El-Demer-dash, E. and Al-Hendy, A. (2009) 2-Methoxyestradiol and multi-drug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Breast Cancer Res Treat 113:9-19.
4. Benninghoff, J., Kartarius, S., Teleb, Z., Selter, H., Unteregger, G., Zwergel, T., et al. (1999) Two different forms of p53 localized differently within cells of urogenital tumours. Cancer Lett 144:55-64. (Pubitemid 29392898)
5. Bradford, M.M. (1976) A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355. (Pubitemid 24259959)
7. Cushman, M., He, H.M., Katzenellenbogen, J.A., Lin, C.M. and Hamel, E. (1995) Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J Med Chem 38:2041-2049.
8. DaposAmato, R.J., Lin, C.M., Flynn, E., Folkman, J. and Hamel, E. (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968. (Pubitemid 24139553)
9. Depalo, R., Lorusso, F., Bettocchi, S., Selvaggi, L., Cavallini, A., Valen-tini, A.M., et al. (2009) Assessment of estrogen receptors and apop-totic factors in cryopreserved human ovarian cortex. Syst Biol Reprod Med 55:236-243.
10. Dinda, S., Kodali-Gali, S., Sevilla, L., Burkley, M., Hurd, C. and Moudgil, V.K. (1997) Inhibition of proliferation of T47D human breast cancer cells: alterations in progesterone receptor and p53 tumor suppressor protein. Mol Cell Biochem 175:81-89. (Pubitemid 27453339)
11. Dinda, S., Sanchez, A. and Moudgil, V. (2002) Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21:761-768. (Pubitemid 34146288)
12. Dinda, S., Sanchez, A. and Moudgil, V.K. (2010) Effects of LY117018 (a SERM analog of raloxifene) on tumor suppressor proteins and proliferation of breast cancer cells. Horm Mol Biol Clin Investig 2:211-217.
13. Donehower, L.A. and Bradley, A. (1993) The tumor suppressor p53. Biochim Biophys Acta 1155:181-205. (Pubitemid 23246695)
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825. (Pubitemid 23346378)
15. Erster, S., Mihara, M., Kim, R.H., Petrenko, O. and Moll, U.M. (2004) In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24:6728-6741. (Pubitemid 38944352)
16. Fotsis, T., Zhang, Y., Pepper, M.S., Adlercreutz, H., Montesano, R., Nawroth, P.P., et al. (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239. (Pubitemid 24108838)
17. Fuchs, S.Y., Adler, V., Buschmann, T., Wu, X. and Ronai, Z. (1998a) Mdm2 association with p53 targets its ubiquitination. Oncogene 17:2543-2547. (Pubitemid 28544725)
18. Fuchs, S.Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S.N., et al. (1998b) JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12:2658-2663. (Pubitemid 28420646)
19. Fuchs, S.Y., Adler, V., Pincus, M.R., and Ronai, Z. (1998c) MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 95:10541-10546. (Pubitemid 28413103)
20. Fukui, M. and Zhu, B.T. (2009) Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol Carcinog 48:66-78.
21. Giannakakou, P., Robey, R., Fojo, T. and Blagosklonny, M.V. (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20:3806-3813. (Pubitemid 32646191)
22. Grover, R., Candeias, M.M., Fahraeus, R. and Das, S. (2009) p53 and little brother p53/47: linking IRES activities with protein functions. Oncogene 28:2766-2772.
23. Halaby, M.J. and Yang, D.Q. (2007) p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395:1-7.
24. Hamel, E., Lin, C.M., Flynn, E. and DaposAmato, R.J. (1996) Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers. Biochemistry 35:1304-1310. (Pubitemid 26050794)
25. Han, G.Z., Liu, Z.J., Shimoi, K. and Zhu, B.T. (2005) Synergism between the anticancer actions of 2-methoxyestradiol and microtu-bule-disrupting agents in human breast cancer. Cancer Res 65:387-393.
26. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296-299. (Pubitemid 27220766)
27. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science 253:49-53. (Pubitemid 21917115)
28. Horky, M., Wurzer, G., Kotala, V., Anton, M., Vojtesek, B., Vacha, J., et al. (2001) Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells. J Cell Sci 114:663-670. (Pubitemid 32237138)
29. Hupp, T.R., Meek, D.W., Midgley, C.A. and Lane, D.P. (1992) Regulation of the specific DNA binding function of p53. Cell 71:875-886.
30. Hurd, C., Khattree, N., Alban, P., Nag, K., Jhanwar, S.C., Dinda, S., et al. (1995) Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J Biol Chem 270:28507-28510.
31. Hurd, C., Nag, K., Khattree, N., Alban, P., Dinda, S. and Moudgil, V.K. (1999) Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells. Mol Cell Biochem 199:49-56. (Pubitemid 29476141)
32. Karni-Schmidt, O., Friedler, A., Zupnick, A., McKinney, K., Mattia, M., Beckerman, R., et al. (2007) Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene 26:3878-3891. (Pubitemid 46878137)
33. Karni-Schmidt, O., Zupnick, A., Castillo, M., Ahmed, A., Matos, T., Bouvet, P., et al. (2008) p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci 121:4098-4105.
34. Klibanov, S.A., OaposHagan, H.M. and Ljungman, M. (2001) Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J Cell Sci 114:1867-1873. (Pubitemid 32530041)
35. Kodali, S., Burkley, M., Nag, K., Taylor, R.C. and Moudgil, V.K. (1994) Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells. Biochem Biophys Res Commun 202:1413-1419. (Pubitemid 24265925)
36. Latonen, L., Kurki, S., Pitkanen, K. and Laiho, M. (2003) p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. Cell Signal 15:95-102. (Pubitemid 35223633)
37. LaVallee, T.M., Zhan, X.H., Herbstritt, C.J., Kough, E.C., Green, S.J. and Pribluda, V.S. (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691-3697. (Pubitemid 34728848)
38. Lee, L.F., Li, G., Templeton, D.J. and Ting, J.P. (1998) Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol Chem 273:28253-28260. (Pubitemid 28496124)
39. Liu, Z.J., Lee, W.J. and Zhu, B.T. (2005) Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause. Cancer Res 65:5802-5811. (Pubitemid 40911184)
40. Liu, Z.J. and Zhu, B.T. (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 88:265-275. (Pubitemid 38553758)
41. Lottering, M.L., Haag, M. and Seegers, J.C. (1992) Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 52:5926-5932.
42. Mabjeesh, N.J., Escuin, D., LaVallee, T.M., Pribluda, V.S., Swartz, G. M., Johnson, M.S., et al. (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375. (Pubitemid 38340305)
43. Maggi, L.B. Jr. and Weber, J.D. (2005) Nucleolar adaptation in human cancer. Cancer investigation 23:599-608. (Pubitemid 43286662)
44. Mannisto, P.T. and Kaakkola, S. (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
45. Martin, M.B., Angeloni, S.V., Garcia-Morales, P., Sholler, P.F., Castro-Galache, M.D., Ferragut, J.A., et al. (2004) Regulation of estrogen receptor-alpha expression in MCF-7 cells by taxol. J Endocrinol 180:487-496. (Pubitemid 38443400)
46. Miglietta, A., Panno, M.L., Bozzo, F., Gabriel, L. and Bocca, C. (2004) Insulin can modulate MCF-7 cell response to paclitaxel. Cancer Lett 209:139-145. (Pubitemid 38670482)
47. Milne, D.M., Campbell, L.E., Campbell, D.G. and Meek, D.W. (1995) p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 270:5511-5518.
48. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
49. Moudgil, V.K., Dinda, S., Khattree, N., Jhanwar, S., Alban, P. and Hurd, C. (2001) Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 76:105-117. (Pubitemid 32510672)
50. Mueck, A.O. and Seeger, H. (2010) 2-Methoxyestradiol-Biology and mechanism of action. Steroids 75:625-631.
51. Mukhopadhyay, T. and Roth, J.A. (1997) Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methox-yestradiol. Oncogene 14:379-384. (Pubitemid 27073094)
52. Nandi, S., Guzman, R.C. and Yang, J. (1995) Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 92:3650-3657.
53. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708. (Pubitemid 20001591)
54. Noguchi, K., Kitanaka, C., Yamana, H., Kokubu, A., Mochizuki, T. and Kuchino, Y. (1999) Regulation of c-Myc through phosphoryl-ation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J Biol Chem 274:32580-32587. (Pubitemid 129535283)
55. Pokrovskaja, K., Mattsson, K., Kashuba, E., Klein, G., and Szekely, L. (2001) Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. J Gen Virol 82:345-358. (Pubitemid 32123888)
56. Pribluda, V.S., Gubish, E.R., Jr., Lavallee, T.M., Treston, A., Swartz, G. M. and Green, S.J. (2000) 2-Methoxyestradiol: an endogenous anti-angiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 19:173-179. (Pubitemid 32004707)
57. Riley, T., Sontag, E., Chen, P. and Levine, A. (2008) Transcriptional control of human pp53-regulated genes. Nat Rev Mol Cell Biol 9:402-412. (Pubitemid 351574202)
58. Rubbi, C.P. and Milner, J. (2000) Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleo-lus. Oncogene 19:85-96. (Pubitemid 30066354)
59. Seegers, J.C., Aveling, M.L., Van Aswegen, C.H., Cross, M., Koch, F. and Joubert, W.S. (1989) The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J Steroid Biochem 32:797-809. (Pubitemid 19192324)
60. Seegers, J.C., Lottering, M.L., Grobler, C.J., van Papendorp, D.H., Habbersett, R.C., Shou, Y., et al. (1997) The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 62:253-267. (Pubitemid 27504756)
61. Shimada, K., Nakamura, M., Ishida, E., Kishi, M. and Konishi, N. (2003) Roles of p38-and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apop-tosis. Carcinogenesis 24:1067-1075. (Pubitemid 36827258)
62. Van Zijl, C., Lottering, M.L., Steffens, F. and Joubert, A. (2008) In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Cell Biochem Funct 26:632-642.
63. Vijayanathan, V., Venkiteswaran, S., Nair, S.K., Verma, A., Thomas, T.J., Zhu, B.T., et al. (2006) Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells. Clin Cancer Res 12:2038-2048.
64. Vogelstein, B., Lane, D. and Levine, A.J. (2000) Surfing the p53 network. Nature 408:307-310.
65. Wesierska-Gadek, J., Schloffer, D., Kotala, V. and Horky, M. (2002) Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int J Cancer 101:128-136. (Pubitemid 34970904)